However, the HSPA8 SNP was also an identifiable factor in several patients’ profiles, and there was no association of the HSPA8 SNP with the hepatic pathological findings, suggesting that it can predict the CVD-specific risk in NAFLD. The gene discussed is HSPA8; the disease is metabolic dysfunction-associated steatotic liver disease.